^
    CANCER:

    Marginal Zone Lymphoma





    Show legend
    Group by Gene:
    ibrutinib
    		0
    BTK inhibitor
    zanubrutinib
    acalabrutinib
    orelabrutinib
    tisagenlecleucel-T
    		1
    CD19-targeted CAR-T immunotherapy
    axicabtagene ciloleucel
    lisocabtagene maraleucel
    2
    CD20 inhibitor
    rituximab
    obinutuzumab
    3
    Alkylating agent
    cyclophosphamide
    chlorambucil
    4
    PI3Kδ inhibitor
    idelalisib
    INCB50465
    5
    PIK3CA inhibitor, PI3Kδ inhibitor
    copanlisib
    6
    PD1 inhibitor
    sintilimab
    G-CHOP
    R-CHOP
    		7
    Chemotherapy
    R-CVP
    ViPOR
    O-CVP
    8
    TNFα inhibitor, IL-12 inhibitor, IL-6 inhibitor, CD20 inhibitor
    rituximab + lenalidomide
    9
    Ionizing radiation emitter, CD20 inhibitor
    ibritumomab tiuxetan
    10
    PI3Kγ inhibitor, PI3Kδ inhibitor
    duvelisib
    11
    Casein kinase I epsilon inhibitor, PI3Kδ inhibitor
    umbralisib
    12
    CD47 inhibitor, CD20 inhibitor
    IMM0306
    No biomarker
    MYD88 L265P
    MYD88 mutation
    CD20 expression + PAX5 expression + BCL2 expression
    TNFAIP3 mutation
    CD20 positive
    LDH elevation
    TP53 mutation + MET amplification + PD-L1 overexpression
    NOTCH2 mutation + NCOA4 mutation + PTEN mutation + EPHA3 mutation + KMT2D mutation
    BIRC3-MALT1 fusion
    CD5 positive
    TP53 mutation
    CARD11 mutation
    KMT2D mutation
    TP53 deletion